Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aytu Biopharma (AYTU) Other financing activities: 2013-2025

Historic Other financing activities for Aytu Biopharma (AYTU) over the last 10 years, with Jun 2025 value amounting to $576,000.

  • Aytu Biopharma's Other financing activities fell 34.10% to $114,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $980,000, marking a year-over-year decrease of 78.49%. This contributed to the annual value of $576,000 for FY2025, which is 80.23% down from last year.
  • According to the latest figures from FY2025, Aytu Biopharma's Other financing activities is $576,000, which was down 80.23% from $2.9 million recorded in FY2024.
  • Aytu Biopharma's 5-year Other financing activities high stood at $6.0 million for FY2023, and its period low was $576,000 during FY2025.
  • For the 3-year period, Aytu Biopharma's Other financing activities averaged around $3.2 million, with its median value being $2.9 million (2024).
  • Per our database at Business Quant, Aytu Biopharma's Other financing activities spiked by 46.84% in 2022 and then plummeted by 80.23% in 2025.
  • Aytu Biopharma's Other financing activities (Yearly) stood at $3.6 million in 2021, then spiked by 46.84% to $5.2 million in 2022, then climbed by 15.21% to $6.0 million in 2023, then crashed by 51.82% to $2.9 million in 2024, then slumped by 80.23% to $576,000 in 2025.